TRIMYRISTIN
Molecular Excipient
Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
---|---|---|---|---|---|---|
723.0 | 14.1 | 0 | 6 | 79.0 | 41 | 0.93 |
- CAS
- 555453
- UNII
- 18L31PSR28
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 31 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code | Date | Title | Phase | Status |
---|---|---|---|---|
NCT01211782 | AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) | Phase 2/Phase 3 | Withdrawn | |
NCT02260973 | 2014-11-01 | The Influence of PRN Omega-3 Nutritional Supplement on Visual Acuity | Phase 2/Phase 3 | Not Yet Recruiting |
NCT02376621 | 2014-10-01 | Bioavailability of Omega-3 Food Supplements in Healthy Subjects | Phase 1 | Completed |
NCT02248948 | 2014-09-01 | Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children | Phase 4 | Recruiting |
NCT02260960 | 2014-03-01 | The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye Disease | Phase 2/Phase 3 | Recruiting |
NCT01848327 | 2013-02-01 | Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis | Phase 2 | Recruiting |
NCT02005900 | 2011-06-01 | Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART. | Phase 3 | Completed |
NCT01252979 | 2010-12-01 | Ketones & Mitochondrial Heteroplasmy | Phase 0 | Completed |
NCT02201368 | 2009-11-01 | Triheptanoin Treatment Trial for Patients With Long-chain Fatty Acid Beta-oxidation Defects | Phase 3 | Withdrawn |
NCT00959010 | 2008-10-01 | Omega 3 Supplementation in Cystic Fibrosis Patients | Phase 3 | Recruiting |
NCT00644098 | 2008-09-01 | Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors | Phase 2 | Completed |
NCT00672763 | 2008-05-01 | Adjuvant Vitamin D With Corticosteroids in Active Crohn's Disease | Phase 4 | Withdrawn |
NCT00292279 | 2002-06-01 | The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients | Phase 3 | Completed |